Status:
UNKNOWN
Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Urolithiasis
Nephrolithiasis
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
In latest literature more evidence is available about the positive effect of alpha blocker on stone expulsion from the ureter. Patients benefit from less pain and shortening time to stone expulsion. O...
Detailed Description
All patients undergoing SWL are included in study. Exclusion criteria: Patient with radio-lucent stone, patients treated with calcium channel blockers, alpha blockers, steroids, patients with contrain...
Eligibility Criteria
Inclusion
- patients undergoing shock wave lithotripsy treatment for urolithiasis.
Exclusion
- patients with abnormal liver function, postural hypotension, alpha-blocker treatment, sensitivity to alpha-blockers, radio-lucent stone, calcium channel blocker treatment, steroids treatment.
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00409227
Start Date
December 1 2006
Last Update
June 18 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endourology unit Urology department Assaf Harofeh MC
Ẕerifin, Israel, 40700